Rockwell Medical (RMTI) Return on Capital Employed Growth (1y) (2012 - 2026)
Rockwell Medical (RMTI) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | -682.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -682.00 |
| Mar 31, 2026 | -1,141.00 |
| Dec 31, 2025 | -1,121.00 |
| Sep 30, 2025 | -1,200.00 |
| Jun 30, 2025 | 531.00 |
| Mar 31, 2025 | 1,925.00 |
| Dec 31, 2024 | 2,004.00 |
| Sep 30, 2024 | 3,524.00 |
| Jun 30, 2024 | 3,778.00 |
| Mar 31, 2024 | 2,267.00 |
| Dec 31, 2023 | 3,263.00 |
| Sep 30, 2023 | 2,828.00 |
| Jun 30, 2023 | 4,276.00 |
| Mar 31, 2023 | 8,654.00 |
| Dec 31, 2022 | 4,156.00 |
| Sep 30, 2022 | 1,409.00 |
| Jun 30, 2022 | 261.00 |
| Mar 31, 2022 | -8,304.00 |
| Dec 31, 2021 | -5,149.00 |
| Sep 30, 2021 | -2,932.00 |